Biosimilars: mimicking biological drugs

Michael Eisenstein

Nature, 2019, vol. 569, issue 7755, S1-S1

Abstract: With the patents on many biological drugs soon to expire, the biosimilars revolution is about to shift into top gear.

Keywords: Drug discovery; Therapeutics; Health care; Intellectual-property rights (search for similar items in EconPapers)
Date: 2019
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/d41586-019-01400-6 Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:569:y:2019:i:7755:d:10.1038_d41586-019-01400-6

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/d41586-019-01400-6

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().